A judge denied a request by Abbott Laboratories (NYSE:ABT) for a new trial after a St. Louis jury awarded a plaintiff $500 million in an infant formula case in July.
Michael Noble of St. Louis City Circuit Court denied the Abbott (
A judge denied a request by Abbott Laboratories (NYSE:ABT) for a new trial after a St. Louis jury awarded a plaintiff $500 million in an infant formula case in July.
Michael Noble of St. Louis City Circuit Court denied the Abbott (